Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VEDOLIZUMAB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

56.5%
Female
43.5%
Male

Age Information

The average age of patients reporting adverse events with VEDOLIZUMAB is 50.0 years.

Geographic Distribution

The majority of adverse event reports for VEDOLIZUMAB originate from CA.

Report Summary & Outcomes

73,857
Total Reports
73,857
As Primary/Secondary Suspect
3,476
Deaths Reported
21,677
Hospitalizations
1,108
Life-Threatening
982
Disabilities

Reporting Timeline

First adverse event report: 19210212. Most recent report: 20250929. View full timeline →

More About VEDOLIZUMAB

VEDOLIZUMAB Full Profile Reports by Year Drug Interactions